Amalia Tejeda-Velarde - JoVE Visualize

Showing results (31-40 of 33) with videos related to

Pageof 4

Sort By:

You have reached the last page of results.This site can display upto 33 results.

Brain : a Journal of Neurology|April 14, 2020

NLRP3 inflammasome as prognostic factor and therapeutic target in primary progressive multiple sclerosis patientsSunny Malhotra, Carme Costa, Herena Eixarch, et al.

Science (New York, N.Y.)|April 23, 2021

Barcoded viral tracing of single-cell interactions in central nervous system inflammationIain C Clark, Cristina Gutiérrez-Vázquez, Michael A Wheeler, et al.

Frontiers in Neurology|January 7, 2021

New Algorithms Improving PML Risk Stratification in MS Patients Treated With NatalizumabInmaculada Toboso, Amalia Tejeda-Velarde, Roberto Alvarez-Lafuente, et al.

Pageof 4

Showing results (31-40 of 33) with videos related to

Sort By:

Pageof 4

You have reached the last page of results.This site can display upto 33 results.

Brain : a Journal of Neurology|April 14, 2020

NLRP3 inflammasome as prognostic factor and therapeutic target in primary progressive multiple sclerosis patientsSunny Malhotra, Carme Costa, Herena Eixarch, et al.

Science (New York, N.Y.)|April 23, 2021

Barcoded viral tracing of single-cell interactions in central nervous system inflammationIain C Clark, Cristina Gutiérrez-Vázquez, Michael A Wheeler, et al.

Frontiers in Neurology|January 7, 2021

New Algorithms Improving PML Risk Stratification in MS Patients Treated With NatalizumabInmaculada Toboso, Amalia Tejeda-Velarde, Roberto Alvarez-Lafuente, et al.

Pageof 4